Disease Burden and Access to Biologic Therapy in Patients with Severe Asthma, 2017–2022 : An Analysis of the International Severe Asthma Registry

Le, T T, Price, D, Erhard, C, Cook, B, Quinton, A, Katial, R, Christoff, G C, Perez-De-Llano, L, Altraja, A, Bergeron , C, Bourdin, A, Koh, M S, Lehtimäki, L, Mahboub, B, Papadopoulos, N G, Pfeffer, P E, Rhee, C K, Carter, V, Martin, N, Tran, T N & EVEREST Study Working Group 2024, 'Disease Burden and Access to Biologic Therapy in Patients with Severe Asthma, 2017–2022 : An Analysis of the International Severe Asthma Registry', Journal of Asthma and Allergy, vol. 2024, no. 17, pp. 1055-1069. https://doi.org/10.2147/JAA.S468068